Fibromyalgia: an update for oral health care providers

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 104, Issue 5, 2007, Pages 589-602

  Balasubramaniam, Ramesh ^a   Laudenbach, Joel M ^a   Stoopler, Eric T ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

BLOOD; DRUG INTERACTION; DYSGEUSIA; FIBROMYALGIA; GLOSSODYNIA; HEADACHE; HUMAN; PAIN; REVIEW; SLEEP DISORDER; TEMPOROMANDIBULAR JOINT DISORDER; XEROSTOMIA;

CYTOKINES; DRUG INTERACTIONS; DYSGEUSIA; FIBROMYALGIA; GLOSSALGIA; HEADACHE; HUMANS; PAIN; SLEEP DISORDERS; TEMPOROMANDIBULAR JOINT DISORDERS; XEROSTOMIA;

EID: 35348967258     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2007.05.010     Document Type: Review

References (191)

1. Kasper D.L., and Harrison T.R. Harrison's principles of internal medicine (2005), McGraw-Hill Book Company, New York
2. Wolfe F., Ross K., Anderson J., and Russell I.J. Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol 22 (1995) 151-156
3. Wolfe F., Anderson J., Harkness D., Bennett R.M., Caro X.J., Goldenberg D.L., et al. Health status and disease severity in fibromyalgia: results of a six-center longitudinal study. Arthritis Rheum 40 (1997) 1571-1579
4. Croft P., Burt J., Schollum J., Thomas E., Macfarlane G., and Silman A. More pain, more tender points: is fibromyalgia just one end of a continuous spectrum?. Ann Rheum Dis 55 (1996) 482-485
5. Croft P., Schollum J., and Silman A. Population study of tender point counts and pain as evidence of fibromyalgia. BMJ 309 (1994) 696-699
6. Croft P. Testing for tenderness: what's the point?. J Rheumatol 27 (2000) 2531-2533
7. Wolfe F., Smythe H.A., Yunus M.B., Bennett R.M., Bombardier C., Goldenberg D.L., et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33 (1990) 160-172
8. Wolfe F., Ross K., Anderson J., Russell I.J., and Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38 (1995) 19-28
9. Pellegrino M.J., Waylonis G.W., and Sommer A. Familial occurrence of primary fibromyalgia. Arch Phys Med Rehabil 70 (1989) 61-63
10. Stormorken H., and Brosstad F. Fibromyalgia: family clustering and sensory urgency with early onset indicate genetic predisposition and thus a "true" disease. Scand J Rheumatol 21 (1992) 207
11. Buskila D., and Neumann L. Fibromyalgia syndrome (FM) and nonarticular tenderness in relatives of patients with FM. J Rheumatol 24 (1997) 941-944
12. Nishikai M. Fibromyalgia in Japanese. J Rheumatol 19 (1992) 110-114
13. Wolfe F. Fibromyalgia. In: Sessle B.J., Bryant P.S., and Dionne R.A. (Eds). Temporomandibular disorders and related conditions (1995), IASP Press, Seattle, WA 31-46
14. Jacobsson L.T., Nagi D.K., Pillemer S.R., Knowler W.C., Hanson R.L., Pettitt D.J., et al. Low prevalences of chronic widespread pain and shoulder disorders among the Pima Indians. J Rheumatol 23 (1996) 907-909
15. White K.P., and Thompson J. Fibromyalgia syndrome in an Amish community: a controlled study to determine disease and symptom prevalence. J Rheumatol 30 (2003) 1835-1840
16. Russell I.J., Fletcher E.M., Michalek J.E., McBroom P.C., and Hester G.G. Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam. A double-blind, placebo-controlled study. Arthritis Rheum 34 (1991) 552-560
17. Hench P.K. Evaluation and differential diagnosis of fibromyalgia. Approach to diagnosis and management. Rheum Dis Clin North Am 15 (1989) 19-29
18. Wolfe F., Cathey M.A., and Kleinheksel S.M. Fibrositis (fibromyalgia) in rheumatoid arthritis. J Rheumatol 11 (1984) 814-818
19. Wallace D.J. The fibromyalgia syndrome. Ann Med 29 (1997) 9-21
20. Hudson J.I., Hudson M.S., Pliner L.F., Goldenberg D.L., and Pope Jr. H.G. Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. Am J Psychiatry 142 (1985) 441-446
21. Adler G.K., Kinsley B.T., Hurwitz S., Mossey C.J., and Goldenberg D.L. Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med 106 (1999) 534-543
22. Crofford L.J., Pillemer S.R., Kalogeras K.T., Cash J.M., Michelson D., Kling M.A., et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 37 (1994) 1583-1592
23. Ferraccioli G., Cavalieri F., Salaffi F., Fontana S., Scita F., Nolli M., et al. Neuroendocrinologic findings in primary fibromyalgia (soft tissue chronic pain syndrome) and in other chronic rheumatic conditions (rheumatoid arthritis, low back pain). J Rheumatol 17 (1990) 869-873
24. Griep E., Boersma J.W., and deKloet E.R. Evidence for neuroendocrine disturbance following physical exercise in primary fibromyalgia syndrome. J Musculoskeletal Pain 1 (1993) 217-222
25. Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl 75 (2005) 6-21
26. Neeck G. Pathogenic mechanisms of fibromyalgia. Ageing Res Rev 1 (2002) 243-255
27. Russell I.J., Vaeroy H., Javors M., and Nyberg F. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 35 (1992) 550-556
28. Eisinger J., Plantamura A., and Ayavou T. Glycolysis abnormalities in fibromyalgia. J Am Coll Nutr 13 (1994) 144-148
29. Russell I.J. Red cell nucleotide abnormalities in fibromyalgia syndrome. Arthritis Rheum 36 (1993) S223
30. Bou-Holaigah I., Calkins H., Flynn J.A., Tunin C., Chang H.C., Kan J.S., et al. Provocation of hypotension and pain during upright tilt table testing in adults with fibromyalgia. Clin Exp Rheumatol 15 (1997) 239-246
31. Martinez-Lavin M., Hermosillo A.G., Rosas M., and Soto M.E. Circadian studies of autonomic nervous balance in patients with fibromyalgia: a heart rate variability analysis. Arthritis Rheum 41 (1998) 1966-1971
32. Thayer J.F., and Friedman B.H. Stop that! Inhibition, sensitization, and their neurovisceral concomitants. Scand J Psychol 43 (2002) 123-130
33. Russell I.J., Michalek J.E., Vipraio G.A., Fletcher E.M., Javors M.A., and Bowden C.A. Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 19 (1992) 104-109
34. Ernberg M., Voog U., Alstergren P., Lundeberg T., and Kopp S. Plasma and serum serotonin levels and their relationship to orofacial pain and anxiety in fibromyalgia. J Orofac Pain 14 (2000) 37-46
35. Vaeroy H., Helle R., Forre O., Kass E., and Terenius L. Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis. Pain 32 (1988) 21-26
36. Russell I.J., Orr M.D., Littman B., Vipraio G.A., Alboukrek D., Michalek J.E., et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 37 (1994) 1593-1601
37. Bennett R.M., Clark S.R., Campbell S.M., and Burckhardt C.S. Low levels of somatomedin C in patients with the fibromyalgia syndrome. A possible link between sleep and muscle pain. Arthritis Rheum 35 (1992) 1113-1116
38. Landis C.A., Lentz M.J., Rothermel J., Riffle S.C., Chapman D., Buchwald D., et al. Decreased nocturnal levels of prolactin and growth hormone in women with fibromyalgia. J Clin Endocrinol Metab 86 (2001) 1672-1678
39. Mense S. Neurobiological concepts of fibromyalgia-the possible role of descending spinal tracts. Scand J Rheumatol Suppl 113 (2000) 24-29
40. Mullington J.M., Hinze-Selch D., and Pollmacher T. Mediators of inflammation and their interaction with sleep: relevance for chronic fatigue syndrome and related conditions. Ann N Y Acad Sci 933 (2001) 201-210
41. Maes M., Libbrecht I., Van Hunsel F., Lin A.H., De Clerck L., Stevens W., et al. The immune-inflammatory pathophysiology of fibromyalgia: increased serum soluble gp130, the common signal transducer protein of various neurotrophic cytokines. Psychoneuroendocrinology 24 (1999) 371-383
42. Wallace D.J., Linker-Israeli M., Hallegua D., Silverman S., Silver D., and Weisman M.H. Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology 40 (2001) 743-749 (Oxford)
43. Torpy D.J., Papanicolaou D.A., Lotsikas A.J., Wilder R.L., Chrousos G.P., and Pillemer S.R. Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia. Arthritis Rheum 43 (2000) 872-880
44. Gur A., Karakoc M., Erdogan S., Nas K., Cevik R., and Sarac A.J. Regional cerebral blood flow and cytokines in young females with fibromyalgia. Clin Exp Rheumatol 20 (2002) 753-760
45. Gur A., Karakoc M., Nas K., Denli A., et al. Cytokines and depression in cases with fibromyalgia. Remzi ?, Cevik ?. J Rheumatol 29 (2002) 358-361
46. Salemi S., Rethage J., Wollina U., Michel B.A., Gay R.E., Gay S., et al. Detection of interleukin 1beta (IL-1beta), IL-6, and tumor necrosis factor-alpha in skin of patients with fibromyalgia. J Rheumatol 30 (2003) 146-150
47. Theoharides T.C., Donelan J.M., Papadopoulou N., Cao J., Kempuraj D., and Conti P. Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol Sci 25 (2004) 563-568
48. Lucas H.J., Brauch C.M., Settas L., and Theoharides T.C. Fibromyalgia-new concepts of pathogenesis and treatment. Int J Immunopathol Pharmacol 19 (2006) 5-10
49. Russell I.J. Fibromyalgia syndrome: approaches to management. Bull Rheum Dis 45 (1996) 1-4
50. Moldofsky H. Management of sleep disorders in fibromyalgia. Rheum Dis Clin North Am 28 (2002) 353-365
51. Moldofsky H. Sleep and pain. Sleep Med Rev 5 (2001) 385-396
52. McBeth J., Macfarlane G.J., Hunt I.M., and Silman A.J. Risk factors for persistent chronic widespread pain: a community-based study. Rheumatology 40 (2001) 95-101 (Oxford)
53. Aaron L.A., and Buchwald D. A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med 134 (2001) 868-881
54. Aaron L.A., and Buchwald D. Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions. Best Pract Res Clin Rheumatol 17 (2003) 563-574
55. Aaron L.A., Burke M.M., and Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med 160 (2000) 221-227
56. Wessely S., Nimnuan C., and Sharpe M. Functional somatic syndromes: one or many?. Lancet 354 (1999) 936-939
57. Clauw D.J., and Crofford L.J. Chronic widespread pain and fibromyalgia: what we know, and what we need to know. Best Pract Res Clin Rheumatol 17 (2003) 685-701
58. Rhodus N.L., Fricton J., Carlson P., and Messner R. Oral symptoms associated with fibromyalgia syndrome. J Rheumatol 30 (2003) 1841-1845
59. Hudson J.I., and Pope Jr. H.G. Fibromyalgia and psychopathology: is fibromyalgia a form of "affective spectrum disorder"?. J Rheumatol Suppl 19 (1989) 15-22
60. Arnold L.M., Hudson J.I., Keck P.E., Auchenbach M.B., Javaras K.N., and Hess E.V. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry 67 (2006) 1219-1225
61. Walker E.A., Keegan D., Gardner G., Sullivan M., Bernstein D., and Katon W.J. Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: II. Sexual, physical, and emotional abuse and neglect. Psychosom Med 59 (1997) 572-577
62. Wigers S.H. Fibromyalgia outcome: the predictive values of symptom duration, physical activity, disability pension, and critical life events-a 4.5 year prospective study. J Psychosom Res 41 (1996) 235-243
63. MacFarlane G.J., Thomas E., Papageorgiou A.C., Schollum J., Croft P.R., and Silman A.J. The natural history of chronic pain in the community: a better prognosis than in the clinic?. J Rheumatol 23 (1996) 1617-1620
64. Hunt I.M., Silman A.J., Benjamin S., McBeth J., and Macfarlane G.J. The prevalence and associated features of chronic widespread pain in the community using the 'Manchester' definition of chronic widespread pain. Rheumatology 38 (1999) 275-279 (Oxford)
65. Sherman J.J., Turk D.C., and Okifuji A. Prevalence and impact of posttraumatic stress disorder-like symptoms on patients with fibromyalgia syndrome. Clin J Pain 16 (2000) 127-134
66. Goldenberg D.L., Burckhardt C., and Crofford L. Management of fibromyalgia syndrome. JAMA 292 (2004) 2388-2395
67. White K.P., Nielson W.R., Harth M., Ostbye T., and Speechley M. Chronic widespread musculoskeletal pain with or without fibromyalgia: psychological distress in a representative community adult sample. J Rheumatol 29 (2002) 588-594
68. Ehrlich G.E. Pain is real; fibromyalgia isn't. J Rheumatol 30 (2003) 1666-1667
69. Pfeiffer A., Thompson J.M., Nelson A., Tucker S., Luedtke C., Finnie S., et al. Effects of a 1.5-day multidisciplinary outpatient treatment program for fibromyalgia: a pilot study. Am J Phys Med Rehabil 82 (2003) 186-191
70. Barkhuizen A. Rational and targeted pharmacologic treatment of fibromyalgia. Rheum Dis Clin North Am 28 (2002) 261-290
71. Carette S., McCain G.A., Bell D.A., and Fam A.G. Evaluation of amitriptyline in primary fibrositis. Arthritis Rheum 29 (1986) 655-659
72. Goldenberg D.L., Felson D.T., and Dinerman H. A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum 29 (1986) 1371-1377
73. Carette S., Bell M.J., Reynolds W.J., Haraoui B., McCain G.A., Bykerk V.P., et al. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial. Arthritis Rheum 37 (1994) 32-40
74. Arnold L.M., Keck Jr. P.E., and Welge J.A. Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics 41 (2000) 104-113
75. O Malley P.G., Balden E., Tomkins G., Santoro J., Kroenke K., and Jackson J.L. Treatment of fibromyalgia with antidepressants: a meta-analysis. J Gen Intern Med 15 (2000) 659-666
76. Arnold L.M., Hess E.V., Hudson J.I., Welge J.A., Berno S.E., and Keck Jr. P.E. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med 112 (2002) 191-197
77. Celiker R., and Cagavi Z. Comparison of amitriptyline and sertaline in the treatment of fibromyalgia syndrome. Arthritis Rheum 43 (2000) S332
78. Anderberg U.M., Marteinsdottir I., and von Knorring L. Citalopram in patients with fibromyalgia-a randomized, double-blind, placebo-controlled study. Eur J Pain 4 (2000) 27-35
79. Capaci K., and Hepguler S. Comparison of the effects of amitriptyline and paroxetine in the treatment of fibromyalgia. Pain Clin 14 (2002) 223-228
80. Dadabhoy D., and Clauw D.J. Fibromyalgia: progress in diagnosis and treatment. Curr Pain Headache Rep 9 (2005) 399-404
81. Kranzler J.D., Gendreau J.F., and Rao S.G. The psychopharmacology of fibromyalgia: a drug development perspective. Psychopharmacol Bull 36 (2002) 165-213
82. Zijsltra T.R., Barendregt P.J., and van de Laar M.A. Venlafaxine in fibromyalgia: results of a randomized placebo-controlled, double-blind trial. [abstract]. Arthritis Rheum 46 (2002) 105
83. Sayar K., Aksu G., Ak I., and Tosun M. Venlafaxine treatment of fibromyalgia. Ann Pharmacother 37 (2003) 1561-1565
84. Gendreau R.M., Mease P.J., Rao S.R., Kranzler J.D., and Clauw D.J. Minacipran: a potential new treatment of fibromyalgia. [abstract]. Arthritis Rheum 48 (2003) 616
85. Arnold L.M., Lu Y., Crofford L.J., Wohlreich M., Detke M.J., Iyengar S., et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 50 (2004) 2974-2984
86. Bennett R.M., Gatter R.A., Campbell S.M., Andrews R.P., Clark S.R., and Scarola J.A. A comparison of cyclobenzaprine and placebo in the management of fibrositis. A double-blind controlled study. Arthritis Rheum 31 (1988) 1535-1542
87. Tofferi J.K., Jackson J.L., and O Malley P.G. Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis. Arthritis Rheum 51 (2004) 9-13
88. Bennett R.M. Pharmacological treatment of fibromyalgia. J Funct Syn 1 (2001) 79-92
89. Russell I.J., Michalek J.E., and Xiao Y. Therapy with a central alpha 2-adrenergic agonist (tizanidine) decreases cerebrospinal fluid substance P, and may reduce serum hyaluronic acid as it improves the clinical symptoms of the fibromyalgia syndrome. Arthritis Rheum 46 (2002) 210
90. Wiffen P., Collins S., McQuay H., Carroll D., Jadad A., and Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev (2000) CD001133
91. Redillas C., and Solomon S. Prophylactic pharmacological treatment of chronic daily headache. Headache 40 (2000) 83-102
92. Crofford L.J., Rowbotham M.C., Mease P.J., Russell I.J., Dworkin R.H., Corbin A.E., et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 52 (2005) 1264-1273
93. Arnold L.M., Goldenberg D.L., Stanford S.B., Lalonde J.K., Sandhu H.S., Keck Jr. P.E., et al. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum 56 (2007) 1336-1344
94. Lautenschlager J. Present state of medication therapy in fibromyalgia syndrome. Scand J Rheumatol Suppl 113 (2000) 32-36
95. Scharf M.B., Baumann M., and Berkowitz D.V. The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia. J Rheumatol 30 (2003) 1070-1074
96. Biasi G., Manca S., Manganelli S., and Marcolongo R. Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo. Int J Clin Pharmacol Res 18 (1998) 13-19
97. Bennett R.M., Kamin M., Karim R., and Rosenthal N. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J Med 114 (2003) 537-545
98. Spath M., Stratz T., Neeck G., Kotter I., Hammel B., Amberger C.C., et al. Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia. Scand J Rheumatol 33 (2004) 267-270
99. Sarzi Puttini P., and Caruso I. Primary fibromyalgia syndrome and 5-hydroxy-L-tryptophan: a 90-day open study. J Int Med Res 20 (1992) 182-189
100. Caruso I., Sarzi Puttini P., Cazzola M., and Azzolini V. Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res 18 (1990) 201-209
101. Bennett R., and Nelson D. Cognitive behavioral therapy for fibromyalgia. Nat Clin Pract Rheumatol 2 (2006) 416-424
102. Williams D.A. Utility of cognitive behavioral therapy as a treatment for insomnia in patients with fibromyalgia. Nat Clin Pract Rheumatol 2 (2006) 190-191
103. Gowans S.E., DeHueck A., and Abbey S.E. Measuring exercise-induced mood changes in fibromyalgia: a comparison of several measures. Arthritis Rheum 47 (2002) 603-609
104. Schachter C.L., Busch A.J., Peloso P.M., and Sheppard M.S. Effects of short versus long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Phys Ther 83 (2003) 340-358
105. Busch A.J., Schachter C.L., Peloso P.M., and Bombardier C. Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev (2003) 3
106. Jones K.D., Burckhardt C.S., Clark S.R., Bennett R.M., and Potempa K.M. A randomized controlled trial of muscle strengthening versus flexibility training in fibromyalgia. J Rheumatol 29 (2002) 1041-1048
107. Jentoft E.S., Kvalvik A.G., and Mengshoel A.M. Effects of pool-based and land-based aerobic exercise on women with fibromyalgia/chronic widespread muscle pain. Arthritis Rheum 45 (2001) 42-47
108. Mannerkorpi K., Nyberg B., Ahlmen M., and Ekdahl C. Pool exercise combined with an education program for patients with fibromyalgia syndrome. A prospective, randomized study. J Rheumatol 27 (2000) 2473-2481
109. Williams D.A. Psychological and behavioural therapies in fibromyalgia and related syndromes. Best Pract Res Clin Rheumatol 17 (2003) 649-665
110. Rossy L.A., Buckelew S.P., Dorr N., Hagglund K.J., Thayer J.F., McIntosh M.J., et al. A meta-analysis of fibromyalgia treatment interventions. Ann Behav Med 21 (1999) 180-191
111. Williams D.A., Cary M.A., Groner K.H., Chaplin W., Glazer L.J., Rodriguez A.M., et al. Improving physical functional status in patients with fibromyalgia: a brief cognitive behavioral intervention. J Rheumatol 29 (2002) 1280-1286
112. Wik G., Fischer H., Bragee B., Finer B., and Fredrikson M. Functional anatomy of hypnotic analgesia: a PET study of patients with fibromyalgia. Eur J Pain 3 (1999) 7-12
113. Berman B.M., Ezzo J., Hadhazy V., and Swyers J.P. Is acupuncture effective in the treatment of fibromyalgia?. J Fam Pract 48 (1999) 213-218
114. Deluze C., Bosia L., Zirbs A., Chantraine A., and Vischer T.L. Electroacupuncture in fibromyalgia: results of a controlled trial. BMJ 305 (1992) 1249-1252
115. Blunt K.L., Rajwani M.H., and Guerriero R.C. The effectiveness of chiropractic management of fibromyalgia patients: a pilot study. J Manipulative Physiol Ther 20 (1997) 389-399
116. Brattberg G. Connective tissue massage in the treatment of fibromyalgia. Eur J Pain 3 (1999) 235-244
117. Ferraccioli G., Ghirelli L., Scita F., Nolli M., Mozzani M., Fontana S., et al. EMG-biofeedback training in fibromyalgia syndrome. J Rheumatol 14 (1987) 820-825
118. Fors E.A., Sexton H., and Gotestam K.G. The effect of guided imagery and amitriptyline on daily fibromyalgia pain: a prospective, randomized, controlled trial. J Psychiatr Res 36 (2002) 179-187
119. Staud R. Are tender point injections beneficial: the role of tonic nociception in fibromyalgia. Curr Pharm Des 12 (2006) 23-27
120. Hong C.Z., and Hsueh T.C. Difference in pain relief after trigger point injections in myofascial pain patients with and without fibromyalgia. Arch Phys Med Rehabil 77 (1996) 1161-1166
121. Almeida T.F., Roizenblatt S., Benedito-Silva A.A., and Tufik S. The effect of combined therapy (ultrasound and interferential current) on pain and sleep in fibromyalgia. Pain 104 (2003) 665-672
122. Buskila D., Abu-Shakra M., Neumann L., Odes L., Shneider E., Flusser D., et al. Balneotherapy for fibromyalgia at the Dead Sea. Rheumatol Int 20 (2001) 105-108
123. Trock D.H. Electromagnetic fields and magnets. Investigational treatment for musculoskeletal disorders. Rheum Dis Clin North Am 26 (2000) 51-62
124. Jonas W.B., Linde K., and Ramirez G. Homeopathy and rheumatic disease. Rheum Dis Clin North Am 26 (2000) 117-123
125. Kramer N. Why I would not recommend complementary or alternative therapies: a physician's perspective. Rheum Dis Clin North Am 25 (1999) 833-843
126. Balderer G., and Borbely A.A. Effect of valerian on human sleep. Psychopharmacology 87 (1985) 406-409 (Berl)
127. Chong S.K., and Oberholzer V.G. Ginseng-is there a use in clinical medicine?. Postgrad Med J 64 (1988) 841-846
128. Ernst E., and Chrubasik S. Phyto-anti-inflammatories. A systematic review of randomized, placebo-controlled, double-blind trials. Rheum Dis Clin North Am 26 (2000) 13-27
129. Citera G., Arias M.A., Maldonado-Cocco J.A., Lazaro M.A., Rosemffet M.G., Brusco L.I., et al. The effect of melatonin in patients with fibromyalgia: a pilot study. Clin Rheumatol 19 (2000) 9-13
130. Abraham G., and Flechas J. Management of fibromyalgia: rationale for use of magnesium and malic acid. J Nutritional Med 3 (1992) 49-59
131. Dessein P.H., Shipton E.A., Joffe B.I., Hadebe D.P., Stanwix A.E., and Van der Merwe B.A. Hyposecretion of adrenal androgens and the relation of serum adrenal steroids, serotonin and insulin-like growth factor-1 to clinical features in women with fibromyalgia. Pain 83 (1999) 313-319
132. Forsyth L.M., Preuss H.G., MacDowell A.L., Chiazze Jr. L., Birkmayer G.D., and Bellanti J.A. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Ann Allergy Asthma Immunol 82 (1999) 185-191
133. Henderson C.J., and Panush R.S. Diets, dietary supplements, and nutritional therapies in rheumatic diseases. Rheum Dis Clin North Am 25 (1999) 937-968
134. Dykman K.D., Tone C.M., and Ford C. The effects of nutritional supplements on the symptoms of fibromyalgia and chronic fatigue syndrome. Integr Physiol Behav Sci 33 (1998) 61-71
135. Fregni F., Gimenes R., Valle A.C., Ferreira M.J., Rocha R.R., Natalle L., et al. A randomized, sham-controlled, proof of principle study of transcranial direct current stimulation for the treatment of pain in fibromyalgia. Arthritis Rheum 54 (2006) 3988-3998
136. Scully C., and Bagan J.V. Adverse drug reactions in the orofacial region. Crit Rev Oral Biol Med 15 (2004) 221-239
137. Smith R.G., and Burtner A.P. Oral side-effects of the most frequently prescribed drugs. Spec Care Dentist 14 (1994) 96-102
138. In: Ciancio S.G. (Ed). ADA/PDR guide to dental therapeutics (2006), American Dental Association and Thomson PDR, Chicago
139. In: Wynn R.L., Meiller T.F., and Crossley H.L. (Eds). Drug information handbook for dentistry (2006), Lexi-Comp, Hudson
140. Okeson J.P. Temporomandibular disorders: guidelines for evaluation, diagnosis, and management. American Academy of Orofacial Pain (1996), Quintessence, Chicago
141. Balasubramaniam R., de Leeuw R., Zhu H., Nickerson R.B., Okeson J.P., and Carlson C.R. Prevalence of temporomandibular disorders in fibromyalgia and failed back syndrome patients: a blinded prospective comparison study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104 (2007) 204-216
142. Hedenberg-Magnusson B., Ernberg M., and Kopp S. Presence of orofacial pain and temporomandibular disorder in fibromyalgia. A study by questionnaire. Swed Dent J 23 (1999) 185-192
143. Plesh O., Wolfe F., and Lane N. The relationship between fibromyalgia and temporomandibular disorders: prevalence and symptom severity. J Rheumatol 23 (1996) 1948-1952
144. McCain G.A., and Scudds R.A. The concept of primary fibromyalgia (fibrositis): clinical value, relation and significance to other chronic musculoskeletal pain syndromes. Pain 33 (1988) 273-287
145. Eriksson P.O., Lindman R., Stal P., and Bengtsson A. Symptoms and signs of mandibular dysfunction in primary fibromyalgia syndrome (PSF) patients. Swed Dent J 12 (1988) 141-149
146. Blasberg B., and Chalmers A. Temporomandibular pain and dysfunction syndrome associated with generalized musculoskeletal pain: a retrospective study. J Rheumatol Suppl 19 (1989) 87-90
147. Fricton J.R. The relationship of temporomandibular disorders and fibromyalgia: implications for diagnosis and treatment. Curr Pain Headache Rep 8 (2004) 355-363
148. Dao T.T., Reynolds W.J., and Tenenbaum H.C. Comorbidity between myofascial pain of the masticatory muscles and fibromyalgia. J Orofac Pain 11 (1997) 232-241
149. Turp J.C., Kowalski C.J., O Leary N., and Stohler C.S. Pain maps from facial pain patients indicate a broad pain geography. J Dent Res 77 (1998) 1465-1472
150. Raphael K.G., Marbach J.J., and Klausner J. Myofascial face pain. Clinical characteristics of those with regional vs. widespread pain. J Am Dent Assoc 131 (2000) 161-171
151. Wolfe F., Katz R.S., and Michaud K. Jaw pain: its prevalence and meaning in patients with rheumatoid arthritis, osteoarthritis, and fibromyalgia. J Rheumatol 32 (2005) 2421-2428
152. Wolfe F. Pain extent and diagnosis: development and validation of the regional pain scale in 12,799 patients with rheumatic disease. J Rheumatol 30 (2003) 369-378
153. Hagberg C., Hagberg M., and Kopp S. Musculoskeletal symptoms and psychosocial factors among patients with craniomandibular disorders. Acta Odontol Scand 52 (1994) 170-177
154. Korszun A., Papadopoulos E., Demitrack M., Engleberg C., and Crofford L. The relationship between temporomandibular disorders and stress-associated syndromes. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 86 (1998) 416-420
155. Hedenberg-Magnusson B., Ernberg M., and Kopp S. Symptoms and signs of temporomandibular disorders in patients with fibromyalgia and local myalgia of the temporomandibular system. A comparative study. Acta Odontol Scand 55 (1997) 344-349
156. Cimino R., Michelotti A., Stradi R., and Farinaro C. Comparison of clinical and psychologic features of fibromyalgia and masticatory myofascial pain. J Orofac Pain 12 (1998) 35-41
157. Vollaro S., Michelotti A., Cimino R., Farella M., and Martina R. [Epidemiologic study of patients with craniomandibular disorders. Report of data and clinical findings]. Minerva Stomatol 50 (2001) 9-14 (in Italian)
158. Wright E.F., Des Rosier K.F., Clark M.K., and Bifano S.L. Identifying undiagnosed rheumatic disorders among patients with TMD. J Am Dent Assoc 128 (1997) 738-744
159. Manfredini D., Tognini F., Montagnani G., Bazzichi L., Bombardieri S., and Bosco M. Comparison of masticatory dysfunction in temporomandibular disorders and fibromyalgia. Minerva Stomatol 53 (2004) 641-650
160. Pennacchio E.A., Borg-Stein J., and Keith D.A. The incidence of pain in the muscles of mastication in patients with fibromyalgia. J Mass Dent Soc 47 (1998) 8-12
161. Carlson P.L., Look J.O., and Lenton P.A. Fibromyalgia: a predictor for progression of TMD chronic pain grade. J Dent Res 80 (2001) 398
162. Dworkin S.F., and LeResche L. Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord 6 (1992) 301-355
163. Randolph C.S., Greene C.S., and Moretti R. Conservative management of temporomandibular disorders: a post treatment comparison between patients from a university clinic and from private practice. Am J Orthod Dentofac Orthop 98 (1990) 77-82
164. Nickerson J.W., and Boering G. Natural course of osteoarthrosis as it relates to internal derangement of the temporomandibular joint. Oral Maxillofac Surg Clin North Am 1 (1989) 1-19
165. Schiffman E.L., Fricton J.R., Haley D.P., and Shapiro B.L. The prevalence and treatment needs of subjects with temporomandibular disorders. J Am Dent Assoc 120 (1990) 295-303
166. Von Korff M., Dworkin S.F., Le Resche L., and Kruger A. An epidemiologic comparison of pain complaints. Pain 32 (1988) 173-183
167. Okeson J.P., and Bell W.E. Bell's orofacial pains: the clinical management of orofacial pain (2005), Quintessence Publishing Co, Chicago
168. Truta M.P., and Santucci E.T. Head and neck fibromyalgia and temporomandibular arthalgia. Otolaryngol Clin North Am 22 (1989) 1159-1171
169. Adiels A.M., Helkimo M., and Magnusson T. Tactile stimulation as a complementary treatment of temporomandibular disorders in patients with fibromyalgia syndrome. A pilot study. Swed Dent J 29 (2005) 17-25
170. Raphael K.G., and Marbach J.J. Widespread pain and the effectiveness of oral splints in myofascial face pain. J Am Dent Assoc 132 (2001) 305-316
171. Bennett R.M. Multidisciplinary group programs to treat fibromyalgia patients. Rheum Dis Clin North Am 22 (1996) 351-367
172. White K.P., Speechly M., Harth M., and Ostbye T. Comparing self-reported function and work disability in 100 community cases of fibromyalgia syndrome versus controls in London, Ontario: the London Fibromyalgia Epidemiology Study. Arthritis Rheum 24 (1999) 76-83
173. Okifuji A., Turk D.C., and Marcus D.A. Comparison of generalized and localized hyperalgesia in patients with recurrent headache and fibromyalgia. Psychosom Med 61 (1999) 771-780
174. Hudson J.I., Goldenberg D.L., Pope Jr. H.G., Keck Jr. P.E., and Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 92 (1992) 363-367
175. Marcus D.A., Bernstein C., and Rudy T.E. Fibromyalgia and headache: an epidemiological study supporting migraine as part of the fibromyalgia syndrome. Clin Rheumatol 24 (2005) 595-601
176. Ifergane G., Buskila D., Simiseshvely N., Zeev K., and Cohen H. Prevalence of fibromyalgia syndrome in migraine patients. Cephalalgia 26 (2005) 451-456
177. Centonze V., Bassi A., Cassiano M.A., Munno I., Dalfino L., and Causarano V. Migraine, daily chronic headache and fibromyalgia in the same patient: an evolutive "continuum" of non organic chronic pain? About 100 clinical cases. Neurol Sci 25 Suppl 3 (2004) S291-S292
178. Burstein R., Yarnitsky D., Goor-Aryeh I., Ransil B.J., and Bajwa Z.H. An association between migraine and cutaneous allodynia. Ann Neurol 47 (2000) 614-624
179. McDermid A.J., Rollman G.B., and McCain G.A. Generalized hypervigilance in fibromyalgia: evidence of perceptual amplification. Pain 66 (1996) 133-144
180. Scudds R.A., Rollman G.B., Harth M., and McCain G.A. Pain perception and personality measures as discriminators in the classification of fibrositis. J Rheumatol 14 (1987) 563-569
181. Guggenheimer J., and Moore P.A. Xerostomia: etiology, recognition and treatment. J Am Dent Assoc 134 (2003) 61-69
182. Abdollahi M., and Radfar M. A review of drug-induced oral reactions. J Contemp Dent Pract 4 (2003) 10-31
183. Romanelli F., Adler D.A., and Bungay K.M. Possible paroxetine-induced bruxism. Ann Pharmacother 30 (1996) 1246-1248
184. Lobbezoo F., van Denderen R.J., Verheij J.G., and Naeije M. Reports of SSRI-associated bruxism in the family physician's office. J Orofac Pain 15 (2001) 340-346
185. Bostwick J.M., and Jaffee M.S. Buspirone as an antidote to SSRI-induced bruxism in 4 cases. J Clin Psychiatry 60 (1999) 857-860
186. Brown E.S., and Hong S.C. Antidepressant-induced bruxism successfully treated with gabapentin. J Am Dent Assoc 130 (1999) 1467-1469
187. Jacobsen P.L., and Chavez E.M. Clinical management of the dental patient taking multiple drugs. J Contemp Dent Pract 6 (2005) 144-151
188. Yagiela J.A. Adverse drug interactions in dental practice: interactions associated with vasoconstrictors. Part V of a series. J Am Dent Assoc 130 (1999) 701-709
189. Goulet J.P., Perusse R., and Turcotte J.Y. Contraindications to vasoconstrictors in dentistry: Part III. Pharmacologic interactions. Oral Surg Oral Med Oral Pathol 74 (1992) 692-697
190. Brown R.S., and Rhodus N.L. Epinephrine and local anesthesia revisited. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100 (2005) 401-408
191. Hersh E.V., and Moore P.A. Drug interactions in dentistry: the importance of knowing your CYPs. J Am Dent Assoc 135 (2004) 298-311